15 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... amphotericin B, 3 to 5 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Recommendations for Preventing ... Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Leishmaniasis #Prevention ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... Encephalitis #IDSA #Prevention ... #Treatment #opportunistic ... #pharmacology
Muscarinic Receptor Agonists and Antagonists 
Muscarinic Receptor Agonists
Methacholine
 • Diagnosis of bronchial airway
Carbachol
 • Glaucorna (topical
neurogenic) • Urinary retention ... symptomatic bradycardia (e.g ... #Antagonists #Medications ... #Pharmacology #
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Infections in HIV-AIDS Preventing ... other factors (e.g ... ., concomitant medications ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Infections in HIV-AIDS Indications ... amphotericin B at 3 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
Recommendations for Preventing ... flucytosine 25 mg/kg ... Cryptococcus #IDSA #Prevention ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... Complex in HIV-AIDS Preventing ... Prophylaxis): Indications ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... Primary Infection Indications ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology